693:
471:
25:
140:
131:
973:
may occur. In the event of such symptoms, the dosage should be reduced or treatment discontinued. Patients should be cautioned against engaging in potentially hazardous activities requiring alertness, such as operating machinery or driving a car.
942:
to the drug. Side effects: 'very rare' excessive relaxation, stomachache, nausea, vertigo, anorexia, drowsiness, skin rashes, diarrhoea, vomiting, indigestion, GI disturbances, insomnia, headache, constipation etc.
863:). If eperisone must be used, the patient is advised to stop breast-feeding for the duration of treatment. Eperisone has been reported to be excreted in breast milk in an animal study (in rats).
1508:
Tanno K, Narimatsu E, Takeyama Y, Asai Y (May 2007). "Infantile case of seizure induced by intoxication after accidental consumption of eperisone hydrochloride, an antispastic agent".
194:
1374:
Yang SI, Park HY, Lee SH, Lee SJ, Han OY, Lim SC, et al. (July 2004). "Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone".
1188:
Yang SI, Park HY, Lee SH, Lee SJ, Han OY, Lim SC, et al. (July 2004). "Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone".
596:
839:
patients are treated with eperisone, a reduced dose is recommended, and the patient should be closely monitored for signs of physiological hypofunction during treatment.
2324:
1249:
Bose K (April 1999). "The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial".
162:
552:
1674:
1547:
692:
1757:
1113:. This has shown promise, with the antispasmodic effect lasting over 24 hours, compared to one to two hours following oral administration.
705:
1231:
1717:
814:
In adults, the usual dose of eperisone is 50–150 mg per day, in divided doses, after meals. However, the dosage is adjusted by the
855:
benefits will outweigh the possible risks associated with treatment. The manufacturers of Myonal recommend the drug not be used during
1287:
806:
system, has shown promising results in laboratory tests on rodents; however, this product is not currently available for human use.
572:
108:
951:
Eperisone should be administered with care in patients with a history of hypersensitivity to any medication, or with disorders of
2314:
1879:
1435:
685:
application of the drug and makes it an attractive choice for patients who require antispasmodic therapy without a reduction in
1742:
538:
248:
224:
1667:
46:
1343:
759:
1707:
1697:
769:
362:
89:
1467:
450:
61:
1422:
for "Evaluation of
Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain" at
42:
35:
2319:
2309:
2186:
1660:
68:
1468:"[A case of eperisone hydrochloride (myonal)--induced drug eruption leading to erythema and angioedema]"
851:
women; therefore the drug should not be used in pregnant women, or women who may be pregnant, if the expected
180:
643:, and suppression of the pain reflex. The drug inhibits the vicious circle of myotonia by decreasing pain,
75:
1893:
1854:
1849:
1804:
632:
439:
2111:
1864:
1747:
1543:
57:
2141:
1844:
1834:
1789:
1779:
1768:
1702:
1047:
875:
815:
732:
671:
580:
InChI=1S/C17H25NO/c1-3-15-7-9-16(10-8-15)17(19)14(2)13-18-11-5-4-6-12-18/h7-10,14H,3-6,11-13H2,1-2H3
1839:
1829:
1799:
1784:
1737:
1063:
466:
269:
187:
1594:"Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery"
1319:"Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study"
798:
Eperisone hydrochloride is available as the brand name preparations Myonal and Epry as 50 mg
2052:
1819:
1814:
1809:
1423:
1399:
1213:
1031:
640:
1593:
1640:
1605:
1525:
1479:
1391:
1266:
1205:
1106:
1043:
803:
799:
721:
419:
152:
2251:
1630:
1517:
1383:
1258:
1197:
1117:
962:
939:
775:
709:
487:
379:
371:
286:
278:
2280:
2120:
2106:
2070:
1936:
1922:
1684:
1442:
1094:
935:
872:
745:
667:
628:
351:
470:
1999:
904:
860:
764:
701:
82:
1294:
2303:
2216:
2206:
2161:
2156:
2151:
2022:
1979:
1964:
1945:
1914:
1904:
1562:
1071:
908:
897:
888:
802:, or as 10% granules for oral administration. An experimental form of the drug, as a
749:
621:
172:
1403:
1318:
1217:
2266:
2125:
2096:
1959:
1954:
1688:
1039:
852:
832:
use, therefore its use in paediatrics cannot be recommended without further study.
207:
202:
1652:
1418:
704:
without reducing muscle power; it is therefore useful during the initial stage of
311:
2261:
2246:
2236:
2196:
2191:
2176:
2171:
2088:
2060:
1974:
1969:
1619:"Mechanisms of action of eperisone on isolated dog saphenous arteries and veins"
1262:
1165:
1158:
1151:
1144:
1110:
1067:
923:
913:
753:
24:
1521:
1350:
2288:
2256:
2226:
2211:
2201:
2181:
2042:
2032:
2017:
2007:
1102:
1098:
966:
891:
881:
829:
652:
648:
514:
342:
983:
Shock and anaphylactoid reactions: In the event of symptoms such as redness,
2037:
2027:
1984:
1487:
1060:
1035:
988:
919:
856:
818:
727:
686:
659:
644:
166:
1529:
1483:
1395:
1270:
1209:
1644:
1609:
122:
2231:
2221:
2146:
2078:
2012:
1989:
1729:
1085:
have been reported in an infant after accidental ingestion of eperisone.
1082:
1027:
1019:
1015:
1011:
996:
970:
958:
848:
822:
782:
738:
678:
663:
636:
322:
999:, etc., treatment should be discontinued and appropriate measures taken.
331:
139:
2241:
1888:
1635:
1618:
1121:
1003:
984:
836:
786:
682:
297:
1387:
1201:
130:
1726:
1023:
992:
700:
Eperisone also facilitates voluntary movement of the upper and lower
430:
399:
952:
691:
681:
when compared with other antispasmodic drugs; this simplifies the
537:
528:
410:
1007:
390:
1656:
1251:
Methods and
Findings in Experimental and Clinical Pharmacology
18:
635:, and demonstrates a variety of effects such as reduction of
1617:
Inoue S, Bian K, Okamura T, Okunishi H, Toda N (July 1989).
455:
828:
Eperisone has not been established as definitely safe for
708:
and as a supporting drug during subsequent rehabilitative
1598:
The
Journal of Pharmacology and Experimental Therapeutics
847:
Eperisone has not been established to be safe for use by
1132:
Eperisone is marketed under many brand names worldwide.
1066:
occurring after the concomitant use of the related drug
260:)-1-(4-Ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one
603:
1109:
containing eperisone is currently in development in
651:
in skeletal muscles, thus alleviating stiffness and
2279:
2134:
2105:
2087:
2069:
2051:
1998:
1944:
1935:
1913:
1878:
1756:
1725:
1716:
1696:
526:
513:
486:
481:
449:
429:
409:
389:
361:
341:
321:
296:
268:
239:
223:
218:
193:
179:
161:
151:
146:
49:. Unsourced material may be challenged and removed.
955:function (it may aggravate hepatic dysfunction).
922:action and inhibition of the pain reflex in the
310:
285:
277:
1282:
1280:
1140:Chemically and mechanistically related drugs:
1668:
1120:agent, with promising results from trials on
724:in conditions such as cerebrovascular disease
8:
1116:Eperisone is also under investigation as an
677:Eperisone has a relatively low incidence of
121:
1059:There have been reports of disturbances in
232:In general: ℞ (Prescription only)
1941:
1722:
1713:
1675:
1661:
1653:
1510:The American Journal of Emergency Medicine
843:Safety during pregnancy and breast-feeding
469:
350:
138:
129:
1634:
995:of the face and other parts of the body,
821:depending on factors such as severity of
378:
370:
109:Learn how and when to remove this message
781:Cervical syndrome, periarthritis of the
2325:Drugs with unknown mechanisms of action
1592:Fujioka M, Kuriyama H (December 1985).
1232:"eperisone Summary Report - CureHunter"
1177:
1097:when taken orally, as a result of high
577:
557:
465:
330:
253:
1183:
1181:
120:
16:Antispasmodic and muscle relaxant drug
1552: Eperisone as a hypotensive agent
741:(including from cerebrospinal tumour)
438:
418:
171:
7:
1338:
1336:
1334:
1332:
206:
47:adding citations to reliable sources
655:, and facilitating muscle movement
398:
301:
1093:Eperisone suffers from a very low
14:
1623:Japanese Journal of Pharmacology
1563:"International eperisone brands"
627:Eperisone acts by relaxing both
504:
498:
23:
778:and other encephalomyelopathies
585:Key:SQUNAWUMZGQQJD-UHFFFAOYSA-N
34:needs additional citations for
1466:Ueno T, Kawana S (July 2007).
916:and augmentation of blood flow
560:CCc1ccc(cc1)C(=O)C(C)CN2CCCCC2
507:
492:
1:
760:Amyotrophic lateral sclerosis
696:Japanese package of eperisone
825:, patient age and response.
770:Spinocerebellar degeneration
1263:10.1358/mf.1999.21.3.534831
2341:
1522:10.1016/j.ajem.2006.09.002
482:Chemical and physical data
1902:Polyalkylene derivatives:
810:Dosage and administration
593:
568:
548:
244:
137:
128:
728:Spastic spinal paralysis
658:Eperisone also improves
173:International Drug Names
2315:1-Piperidinyl compounds
938:in patients with known
633:vascular smooth muscles
618:eperisone hydrochloride
1915:ACh release inhibitors
1797:intermediate duration:
1416:Clinical trial number
1344:"Myonal Tablets 50 mg"
697:
1766:ultra-short duration:
695:
2142:Arbaclofen placarbil
1835:Dimethyltubocurarine
1743:Dimethyltubocurarine
1002:Other side effects:
800:sugar-coated tablets
733:Cervical spondylosis
672:cervical spondylosis
43:improve this article
1889:Choline derivatives
1698:Peripherally acting
1089:Future developments
616:(formulated as the
125:
2053:Nonbenzodiazepines
1758:4° ammonium agents
1636:10.1254/jjp.50.271
1424:ClinicalTrials.gov
1325:. 17 October 2012.
1323:europeanreview.org
1236:www.curehunter.com
1078:Safety in overdose
1070:hydrochloride and
1034:, abdominal pain,
698:
2297:
2296:
2275:
2274:
1931:
1930:
1896:(Succinylcholine)
1874:
1873:
1388:10.1159/000077449
1202:10.1159/000077449
1107:transdermal patch
1055:Drug interactions
1044:urinary retention
930:Contraindications
804:transdermal patch
776:vascular diseases
722:Spastic paralysis
639:, improvement of
611:
610:
539:Interactive image
451:CompTox Dashboard
119:
118:
111:
93:
2332:
2320:Aromatic ketones
2310:Muscle relaxants
2252:Thiocolchicoside
2107:Anticholinergics
2071:Thienodiazepines
1942:
1937:Centrally acting
1867:(Hexafluorenium)
1723:
1718:Non-depolarizing
1714:
1685:muscle relaxants
1677:
1670:
1663:
1654:
1648:
1638:
1613:
1578:
1577:
1575:
1573:
1559:
1553:
1551:
1550:
1546:
1540:
1534:
1533:
1505:
1499:
1498:
1496:
1495:
1486:. Archived from
1463:
1457:
1456:
1454:
1453:
1447:
1441:. Archived from
1440:
1432:
1426:
1414:
1408:
1407:
1371:
1365:
1364:
1362:
1361:
1355:
1349:. Archived from
1348:
1340:
1327:
1326:
1315:
1309:
1308:
1306:
1305:
1299:
1293:. Archived from
1292:
1284:
1275:
1274:
1246:
1240:
1239:
1228:
1222:
1221:
1185:
1118:antihypertensive
963:light-headedness
940:hypersensitivity
907:sensitivity via
884:skeletal muscles
666:associated with
629:skeletal muscles
607:
606:
599:
541:
521:
509:
506:
500:
494:
474:
473:
459:
457:
442:
422:
402:
382:
374:
354:
334:
314:
304:
303:
289:
281:
210:
175:
142:
133:
126:
124:
114:
107:
103:
100:
94:
92:
51:
27:
19:
2340:
2339:
2335:
2334:
2333:
2331:
2330:
2329:
2300:
2299:
2298:
2293:
2281:Directly acting
2271:
2130:
2121:Cyclobenzaprine
2112:Antimuscarinics
2109:
2101:
2083:
2065:
2047:
2000:Benzodiazepines
1994:
1927:
1923:Botulinum toxin
1909:
1870:
1752:
1706:
1700:
1692:
1681:
1651:
1616:
1591:
1587:
1585:Further reading
1582:
1581:
1571:
1569:
1561:
1560:
1556:
1548:
1542:
1541:
1537:
1507:
1506:
1502:
1493:
1491:
1474:(in Japanese).
1465:
1464:
1460:
1451:
1449:
1445:
1438:
1434:
1433:
1429:
1415:
1411:
1373:
1372:
1368:
1359:
1357:
1353:
1346:
1342:
1341:
1330:
1317:
1316:
1312:
1303:
1301:
1297:
1290:
1286:
1285:
1278:
1248:
1247:
1243:
1230:
1229:
1225:
1187:
1186:
1179:
1174:
1138:
1130:
1095:bioavailability
1091:
1080:
1057:
980:
949:
936:contraindicated
932:
896:Suppression of
873:Skeletal muscle
869:
845:
812:
796:
718:
668:cerebrovascular
602:
600:
597:(what is this?)
594:
589:
586:
581:
576:
575:
564:
561:
556:
555:
544:
519:
503:
497:
477:
453:
445:
425:
405:
385:
357:
337:
317:
300:
292:
264:
261:
252:
251:
235:
214:
182:
115:
104:
98:
95:
52:
50:
40:
28:
17:
12:
11:
5:
2338:
2336:
2328:
2327:
2322:
2317:
2312:
2302:
2301:
2295:
2294:
2292:
2291:
2285:
2283:
2277:
2276:
2273:
2272:
2270:
2269:
2264:
2259:
2254:
2249:
2244:
2239:
2234:
2229:
2224:
2219:
2214:
2209:
2204:
2199:
2194:
2189:
2184:
2179:
2174:
2169:
2164:
2159:
2154:
2149:
2144:
2138:
2136:
2132:
2131:
2129:
2128:
2123:
2117:
2115:
2103:
2102:
2100:
2099:
2093:
2091:
2085:
2084:
2082:
2081:
2075:
2073:
2067:
2066:
2064:
2063:
2057:
2055:
2049:
2048:
2046:
2045:
2040:
2035:
2030:
2025:
2020:
2015:
2010:
2004:
2002:
1996:
1995:
1993:
1992:
1987:
1982:
1977:
1972:
1967:
1962:
1957:
1951:
1949:
1939:
1933:
1932:
1929:
1928:
1926:
1925:
1919:
1917:
1911:
1910:
1908:
1907:
1898:
1897:
1884:
1882:
1876:
1875:
1872:
1871:
1869:
1868:
1858:
1857:
1852:
1847:
1842:
1837:
1832:
1827:long duration:
1823:
1822:
1817:
1812:
1807:
1802:
1793:
1792:
1787:
1782:
1776:short duration
1772:
1771:
1762:
1760:
1754:
1753:
1751:
1750:
1745:
1740:
1734:
1732:
1720:
1711:
1694:
1693:
1682:
1680:
1679:
1672:
1665:
1657:
1650:
1649:
1629:(3): 271–282.
1614:
1604:(3): 757–763.
1588:
1586:
1583:
1580:
1579:
1554:
1535:
1516:(4): 481–482.
1500:
1478:(7): 709–713.
1458:
1427:
1409:
1382:(3): 150–156.
1366:
1328:
1310:
1276:
1257:(3): 209–213.
1241:
1223:
1196:(3): 150–156.
1176:
1175:
1173:
1170:
1169:
1168:
1162:
1161:
1155:
1154:
1148:
1147:
1137:
1134:
1129:
1126:
1090:
1087:
1079:
1076:
1056:
1053:
1052:
1051:
1014:, sleepiness,
1000:
979:
976:
948:
945:
931:
928:
927:
926:
917:
914:Vasodilatation
911:
905:muscle spindle
901:
894:
885:
880:Relaxation of
878:
868:
865:
861:breast-feeding
844:
841:
811:
808:
795:
792:
791:
790:
779:
772:
767:
765:Cerebral palsy
762:
757:
742:
737:Postoperative
735:
730:
725:
717:
714:
706:rehabilitation
609:
608:
591:
590:
588:
587:
584:
582:
579:
571:
570:
569:
566:
565:
563:
562:
559:
551:
550:
549:
546:
545:
543:
542:
534:
532:
524:
523:
517:
511:
510:
501:
495:
490:
484:
483:
479:
478:
476:
475:
462:
460:
447:
446:
444:
443:
435:
433:
427:
426:
424:
423:
415:
413:
407:
406:
404:
403:
395:
393:
387:
386:
384:
383:
375:
367:
365:
359:
358:
356:
355:
347:
345:
339:
338:
336:
335:
327:
325:
319:
318:
316:
315:
307:
305:
294:
293:
291:
290:
282:
274:
272:
266:
265:
263:
262:
255:
247:
246:
245:
242:
241:
237:
236:
234:
233:
229:
227:
221:
220:
216:
215:
213:
212:
199:
197:
191:
190:
185:
183:administration
177:
176:
169:
159:
158:
155:
149:
148:
144:
143:
135:
134:
117:
116:
31:
29:
22:
15:
13:
10:
9:
6:
4:
3:
2:
2337:
2326:
2323:
2321:
2318:
2316:
2313:
2311:
2308:
2307:
2305:
2290:
2287:
2286:
2284:
2282:
2278:
2268:
2265:
2263:
2260:
2258:
2255:
2253:
2250:
2248:
2245:
2243:
2240:
2238:
2235:
2233:
2230:
2228:
2225:
2223:
2220:
2218:
2217:Methocarbamol
2215:
2213:
2210:
2208:
2207:Mephenoxalone
2205:
2203:
2200:
2198:
2195:
2193:
2190:
2188:
2185:
2183:
2180:
2178:
2175:
2173:
2170:
2168:
2165:
2163:
2162:Chlorzoxazone
2160:
2158:
2157:Chlorphenesin
2155:
2153:
2152:Chlormezanone
2150:
2148:
2145:
2143:
2140:
2139:
2137:
2133:
2127:
2124:
2122:
2119:
2118:
2116:
2113:
2108:
2104:
2098:
2095:
2094:
2092:
2090:
2086:
2080:
2077:
2076:
2074:
2072:
2068:
2062:
2059:
2058:
2056:
2054:
2050:
2044:
2041:
2039:
2036:
2034:
2031:
2029:
2026:
2024:
2023:Flunitrazepam
2021:
2019:
2016:
2014:
2011:
2009:
2006:
2005:
2003:
2001:
1997:
1991:
1988:
1986:
1983:
1981:
1980:Phenprobamate
1978:
1976:
1973:
1971:
1968:
1966:
1965:Difebarbamate
1963:
1961:
1958:
1956:
1953:
1952:
1950:
1947:
1946:Carbamic acid
1943:
1940:
1938:
1934:
1924:
1921:
1920:
1918:
1916:
1912:
1906:
1905:Hexamethonium
1903:
1900:
1899:
1895:
1894:Suxamethonium
1892:
1890:
1886:
1885:
1883:
1881:
1877:
1866:
1865:Hexafluronium
1863:
1860:
1859:
1856:
1853:
1851:
1848:
1846:
1843:
1841:
1838:
1836:
1833:
1831:
1828:
1825:
1824:
1821:
1818:
1816:
1813:
1811:
1808:
1806:
1805:Cisatracurium
1803:
1801:
1798:
1795:
1794:
1791:
1788:
1786:
1783:
1781:
1777:
1774:
1773:
1770:
1767:
1764:
1763:
1761:
1759:
1755:
1749:
1746:
1744:
1741:
1739:
1736:
1735:
1733:
1731:
1728:
1724:
1721:
1719:
1715:
1712:
1709:
1704:
1703:antinicotinic
1699:
1695:
1690:
1686:
1678:
1673:
1671:
1666:
1664:
1659:
1658:
1655:
1646:
1642:
1637:
1632:
1628:
1624:
1620:
1615:
1611:
1607:
1603:
1599:
1595:
1590:
1589:
1584:
1568:
1564:
1558:
1555:
1545:
1539:
1536:
1531:
1527:
1523:
1519:
1515:
1511:
1504:
1501:
1490:on 2014-12-19
1489:
1485:
1481:
1477:
1473:
1469:
1462:
1459:
1448:on 2010-11-28
1444:
1437:
1431:
1428:
1425:
1421:
1420:
1413:
1410:
1405:
1401:
1397:
1393:
1389:
1385:
1381:
1377:
1370:
1367:
1356:on 2009-12-29
1352:
1345:
1339:
1337:
1335:
1333:
1329:
1324:
1320:
1314:
1311:
1300:on 2009-02-06
1296:
1289:
1283:
1281:
1277:
1272:
1268:
1264:
1260:
1256:
1252:
1245:
1242:
1237:
1233:
1227:
1224:
1219:
1215:
1211:
1207:
1203:
1199:
1195:
1191:
1184:
1182:
1178:
1171:
1167:
1164:
1163:
1160:
1157:
1156:
1153:
1150:
1149:
1146:
1143:
1142:
1141:
1135:
1133:
1127:
1125:
1123:
1119:
1114:
1112:
1108:
1104:
1100:
1096:
1088:
1086:
1084:
1077:
1075:
1073:
1072:methocarbamol
1069:
1065:
1064:accommodation
1062:
1054:
1049:
1045:
1041:
1037:
1033:
1029:
1025:
1021:
1017:
1013:
1009:
1005:
1001:
998:
994:
990:
986:
982:
981:
977:
975:
972:
968:
964:
960:
956:
954:
946:
944:
941:
937:
934:Eperisone is
929:
925:
921:
918:
915:
912:
910:
909:motor neurons
906:
903:Reduction of
902:
899:
898:spinal reflex
895:
893:
890:
889:intramuscular
886:
883:
879:
877:
874:
871:
870:
866:
864:
862:
858:
854:
850:
842:
840:
838:
833:
831:
826:
824:
820:
817:
809:
807:
805:
801:
793:
788:
784:
780:
777:
773:
771:
768:
766:
763:
761:
758:
755:
751:
750:spinal trauma
747:
743:
740:
736:
734:
731:
729:
726:
723:
720:
719:
715:
713:
711:
707:
703:
694:
690:
688:
684:
680:
675:
673:
670:disorders or
669:
665:
661:
656:
654:
650:
646:
642:
638:
634:
630:
625:
623:
622:antispasmodic
619:
615:
605:
598:
592:
583:
578:
574:
567:
558:
554:
547:
540:
536:
535:
533:
530:
525:
518:
516:
512:
491:
489:
485:
480:
472:
468:
467:DTXSID5040671
464:
463:
461:
452:
448:
441:
440:ChEMBL1902981
437:
436:
434:
432:
428:
421:
417:
416:
414:
412:
408:
401:
397:
396:
394:
392:
388:
381:
376:
373:
369:
368:
366:
364:
360:
353:
349:
348:
346:
344:
340:
333:
329:
328:
326:
324:
320:
313:
309:
308:
306:
299:
295:
288:
283:
280:
276:
275:
273:
271:
267:
259:
254:
250:
243:
238:
231:
230:
228:
226:
222:
217:
209:
204:
201:
200:
198:
196:
192:
189:
186:
184:
178:
174:
170:
168:
164:
160:
156:
154:
150:
147:Clinical data
145:
141:
136:
132:
127:
113:
110:
102:
91:
88:
84:
81:
77:
74:
70:
67:
63:
60: –
59:
55:
54:Find sources:
48:
44:
38:
37:
32:This article
30:
26:
21:
20:
2267:Zoxazolamine
2166:
2126:Orphenadrine
2097:Methaqualone
2089:Quinazolines
1960:Cyclarbamate
1955:Carisoprodol
1901:
1887:
1880:Depolarizing
1861:
1845:Pipecuronium
1826:
1796:
1780:Rapacuronium
1775:
1765:
1748:Tubocurarine
1626:
1622:
1601:
1597:
1570:. Retrieved
1566:
1557:
1538:
1513:
1509:
1503:
1492:. Retrieved
1488:the original
1475:
1471:
1461:
1450:. Retrieved
1443:the original
1430:
1417:
1412:
1379:
1376:Pharmacology
1375:
1369:
1358:. Retrieved
1351:the original
1322:
1313:
1302:. Retrieved
1295:the original
1254:
1250:
1244:
1235:
1226:
1193:
1190:Pharmacology
1189:
1139:
1131:
1115:
1092:
1081:
1058:
1048:incontinence
1040:constipation
978:Side effects
957:
950:
933:
867:Pharmacology
846:
834:
827:
813:
797:
794:Presentation
744:Sequelae to
699:
676:
657:
626:
620:salt) is an
617:
613:
612:
601:
595:
257:
225:Legal status
219:Legal status
105:
99:January 2024
96:
86:
79:
72:
65:
53:
41:Please help
36:verification
33:
2262:Tolperisone
2247:Silperisone
2237:Promoxolane
2197:Lanperisone
2192:Inaperisone
2177:Flopropione
2172:Fenyramidol
2061:Eszopiclone
1975:Meprobamate
1970:Febarbamate
1840:Pancuronium
1769:Gantacurium
1701:(primarily
1419:NCT00327730
1166:Tolperisone
1159:Silperisone
1152:Lanperisone
1145:Inaperisone
1128:Brand names
1111:South Korea
1101:intestinal
1068:tolperisone
924:spinal cord
853:therapeutic
816:prescribing
754:head injury
716:Indications
702:extremities
641:circulation
522: g·mol
420:CHEBI:77069
240:Identifiers
153:Trade names
58:"Eperisone"
2304:Categories
2289:Dantrolene
2257:Tizanidine
2227:Pregabalin
2212:Metaxalone
2202:Mephenesin
2182:Gabapentin
2043:Tetrazepam
2033:Nitrazepam
2018:Clonazepam
2008:Bromazepam
1830:Doxacurium
1820:Vecuronium
1815:Rocuronium
1810:Fazadinium
1800:Atracurium
1790:Chandonium
1785:Mivacurium
1738:Alcuronium
1544:EP 0310259
1494:2008-09-28
1472:Arerugi =
1452:2010-06-12
1360:2008-09-01
1304:2008-09-01
1172:References
1103:metabolism
1099:first pass
967:sleepiness
900:potentials
892:blood flow
882:hypertonic
876:relaxation
830:paediatric
653:spasticity
649:hypertonia
527:3D model (
515:Molar mass
380:U38O8U7P6X
377:HCl:
372:2M2P0551D3
343:ChemSpider
287:56839-43-1
284:HCl:
279:64840-90-0
270:CAS Number
249:IUPAC name
69:newspapers
2167:Eperisone
2038:Temazepam
2028:Lorazepam
1985:Styramate
1862:unsorted:
1855:Gallamine
1850:Laudexium
1730:alkaloids
1708:NMJ block
1683:Skeletal
1567:Drugs.com
1436:"Myonil®"
1288:"Myonil®"
1036:diarrhoea
989:urticaria
969:or other
920:Analgesic
887:Improves
857:lactation
819:clinician
687:alertness
660:dizziness
645:ischaemia
614:Eperisone
181:Routes of
167:Drugs.com
123:Eperisone
2232:Pridinol
2222:Phenibut
2147:Baclofen
2079:Etizolam
2013:Diazepam
1990:Tybamate
1572:10 March
1530:17499672
1484:17671415
1404:24474033
1396:15161997
1271:10389124
1218:24474033
1210:15161997
1136:See also
1083:Seizures
1032:anorexia
1028:vomiting
1020:headache
1016:insomnia
1012:pruritus
997:dyspnoea
971:symptoms
959:Weakness
947:Cautions
849:pregnant
823:symptoms
783:shoulder
739:sequelae
683:clinical
679:sedation
664:tinnitus
637:myotonia
604:(verify)
323:DrugBank
195:ATC code
2242:Quinine
1645:2761129
1610:3935775
1122:beagles
1004:anaemia
985:itching
837:elderly
787:lumbago
774:Spinal
710:therapy
520:259.393
488:Formula
332:DB08992
298:PubChem
211:)
205: (
203:M03BX09
83:scholar
1948:esters
1727:Curare
1643:
1608:
1549:
1528:
1482:
1402:
1394:
1269:
1216:
1208:
1061:ocular
1024:nausea
993:oedema
785:, and
748:(e.g.
746:trauma
647:, and
624:drug.
553:SMILES
431:ChEMBL
400:D01671
157:Myonal
85:
78:
71:
64:
56:
2135:Other
1446:(PDF)
1439:(PDF)
1400:S2CID
1354:(PDF)
1347:(PDF)
1298:(PDF)
1291:(PDF)
1214:S2CID
953:liver
573:InChI
529:JSmol
411:ChEBI
90:JSTOR
76:books
1641:PMID
1606:PMID
1574:2016
1526:PMID
1480:PMID
1392:PMID
1267:PMID
1206:PMID
1105:; a
1026:and
1008:rash
662:and
631:and
391:KEGG
363:UNII
352:3123
312:3236
163:AHFS
62:news
2187:GHB
1689:M03
1631:doi
1602:235
1518:doi
1384:doi
1259:doi
1198:doi
1046:or
835:If
752:or
456:EPA
302:CID
258:2RS
208:WHO
188:Ora
45:by
2306::
1778::
1639:.
1627:50
1625:.
1621:.
1600:.
1596:.
1565:.
1524:.
1514:25
1512:.
1476:56
1470:.
1398:.
1390:.
1380:71
1378:.
1331:^
1321:.
1279:^
1265:.
1255:21
1253:.
1234:.
1212:.
1204:.
1194:71
1192:.
1180:^
1124:.
1074:.
1042:,
1038:,
1030:,
1022:,
1018:,
1010:,
1006:,
991:,
987:,
965:,
961:,
712:.
689:.
674:.
502:25
496:17
2114:)
2110:(
1891::
1710:)
1705:,
1691:)
1687:(
1676:e
1669:t
1662:v
1647:.
1633::
1612:.
1576:.
1532:.
1520::
1497:.
1455:.
1406:.
1386::
1363:.
1307:.
1273:.
1261::
1238:.
1220:.
1200::
1050:.
859:(
789:.
756:)
531:)
508:O
505:N
499:H
493:C
458:)
454:(
256:(
165:/
112:)
106:(
101:)
97:(
87:·
80:·
73:·
66:·
39:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
